Low-dose fluoroscopy strategy transforms first-time atrial fibrillation catheter ablation :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Near-zero fluoroscopy AF ablation achieves 82% 1-year freedom from arrhythmia

Atrial fibrillation Atrial fibrillation
Atrial fibrillation Atrial fibrillation

What's new?

Near-zero fluoroscopy catheter ablation for atrial fibrillation achieves 26-second radiation exposure, <1% complications, and durable one-year arrhythmia-free survival.

A prospective registry of 450 patients demonstrates that near-zero fluoroscopy catheter ablation for atrial fibrillation (AF) can be performed efficiently and safely using advanced 3D electroanatomical mapping and an ultra-low-dose radiation protocol—without intracardiac echocardiography or non-fluoroscopic catheter tracking systems.

Catheter ablation remains central to rhythm control in AF, but cumulative radiation exposure is a growing concern for both patients and electrophysiologists. The SHORT LOOK study evaluated whether a simplified pulmonary vein isolation (PVI) workflow—using the CARTO 3 platform alone—could reliably achieve near-zero fluoroscopy in first-time AF ablation. This investigator-initiated, single-center study enrolled consecutive people undergoing first-time PVI.

Baseline assessments encompassed clinical evaluation, laboratory testing, electrocardiography (ECG), echocardiography, and Euro quality of life-visual analog scale (EQ-VAS) scoring. The key efficacy endpoint was median fluoroscopy time, while the key safety endpoint was a composite of procedure-linked death or vascular, cardiovascular, or neurological complications. Secondary measures included 1-year freedom from atrial arrhythmia (>30 seconds), procedural duration, fluoroscopy dose, and quality-of-life changes.

The streamlined workflow delivered strong efficiency with a median procedure time of 57 minutes. Radiation exposure was exceptionally low, with a median fluoroscopy time of just 26 seconds and a median dose of 9.1 µGy·m². The overall complication rate was below 1%, and no major adverse events or procedure-related deaths were reported. Paroxysmal atrial fibrillation shows higher sustained AT/AF-free rates at both 3 and 12 months compared to persistent atrial fibrillation, indicating better long-term rhythm control (Table 1).

 

Patients also experienced remarkable improvement in EQ-VAS scores, reinforcing meaningful clinical benefit. To sum up, ar-zero fluoroscopy AF ablation is achievable using conventional tools already available in electrophysiology laboratories. The approach nearly eliminates radiation exposure, maintains procedural speed, preserves safety, and delivers durable one-year outcomes—without the cost or complexity of additional imaging or tracking technologies.
 

 

Source:

Journal of Cardiovascular Electrophysiology

Article:

Near-Zero-Fluoroscopy Ablation of Atrial Fibrillation Without ICE or Non-Fluoroscopic Tracking Systems: Findings From the SHORT LOOK Registry

Authors:

Martin Borlich et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: